REG - Primary Health Props - Notice of Preliminary Results

Primary Health PropertiesAnnouncement

16/01/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230116:nRSP7289Ma&default-theme=true

RNS Number : 7289M  Primary Health Properties PLC  16 January 2023

16 January 2023

 

Primary Health Properties PLC

Notice of Preliminary Results

 

Primary Health Properties PLC (LSE: PHP), one of the UK's leading investors in
modern primary healthcare facilities, will announce its preliminary results
for the year ended 31 December 2022 on Wednesday, 22 February 2023.

 

A presentation for analysts will be held at Buchanan Communications on the day
of results at 9.30am and will also be accessible via live video webcast and a
live conference call facility. Following the presentation there will be a
moderated Q&A session.

 

To access the briefing, please log on or dial in shortly before 09.30am via
the details below:

 

Webcast: https://stream.brrmedia.co.uk/broadcast/63c1667fddbb3277238eaa71
(https://stream.brrmedia.co.uk/broadcast/63c1667fddbb3277238eaa71)

 

Tel: +44 (0) 33 0551 0200

Password: Quote "PHP results" when prompted

 

If you would like to register your interest in attending the meeting, please
contact Buchanan at php@buchanan.uk.com (mailto:php@buchanan.uk.com) .

 

A recording of the webcast will be made available from c.12.00pm on 22
February on the PHP website, https://www.phpgroup.co.uk/
(https://www.phpgroup.co.uk/) .

 

-Ends-

 

 

Further details:

 

 Harry Hyman                                                    Richard Howell

 Chief Executive Officer                                        Chief Financial Officer

 Tel: 07973 344 768                                             Tel: 0776 6072 272

 David Rydell / Jamie Hooper / Hannah Ratcliff / Verity Parker

 Buchanan Communications

 Tel: +44 (0) 20 7466 5066

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORBJMFTMTBBBMJ